- Home
- DNLI vs PBI Comparison
DNLI vs PBI Comparison
Compare DNLI & PBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNLI
- PBI
- Stock Information
- Founded
- DNLI 2013
- PBI 1920
- Country
- DNLI United States
- PBI United States
- Employees
- DNLI N/A
- PBI N/A
- Industry
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- PBI Office Equipment/Supplies/Services
- Sector
- DNLI Health Care
- PBI Miscellaneous
- Exchange
- DNLI Nasdaq
- PBI Nasdaq
- Market Cap
- DNLI 2.2B
- PBI 2.0B
- IPO Year
- DNLI 2017
- PBI N/A
- Fundamental
- Price
- DNLI $14.85
- PBI $9.53
- Analyst Decision
- DNLI Strong Buy
- PBI Hold
- Analyst Count
- DNLI 13
- PBI 1
- Target Price
- DNLI $32.64
- PBI $11.00
- AVG Volume (30 Days)
- DNLI 1.5M
- PBI 2.6M
- Earning Date
- DNLI 11-03-2025
- PBI 10-29-2025
- Dividend Yield
- DNLI N/A
- PBI 3.34%
- EPS Growth
- DNLI N/A
- PBI N/A
- EPS
- DNLI N/A
- PBI 0.45
- Revenue
- DNLI N/A
- PBI $1,931,125,000.00
- Revenue This Year
- DNLI N/A
- PBI N/A
- Revenue Next Year
- DNLI $94,232.03
- PBI N/A
- P/E Ratio
- DNLI N/A
- PBI $21.36
- Revenue Growth
- DNLI N/A
- PBI N/A
- 52 Week Low
- DNLI $10.57
- PBI $6.88
- 52 Week High
- DNLI $33.33
- PBI $13.11
- Technical
- Relative Strength Index (RSI)
- DNLI 42.38
- PBI 25.44
- Support Level
- DNLI $15.53
- PBI $10.80
- Resistance Level
- DNLI $17.02
- PBI $9.96
- Average True Range (ATR)
- DNLI 0.75
- PBI 0.43
- MACD
- DNLI -0.23
- PBI -0.22
- Stochastic Oscillator
- DNLI 9.18
- PBI 6.49
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
About PBI Pitney Bowes Inc.
Pitney Bowes Inc is a technology-driven company that provides SaaS shipping solutions, mailing innovation, and financial services to clients around the globe. The company's reportable segments are SendTech Solutions and Presort Services. SendTech Solutions includes the revenue and related expenses from physical and digital mailing and shipping technology solutions, financing, services, supplies and other applications to help simplify and save on the sending, tracking and receiving of letters, parcels and flats. Presort Services includes the revenue and related expenses from sortation services to qualify large volumes of First Class Mail, Marketing Mail and Marketing Mail Flats/Bound Printed Matter for postal worksharing discounts. It derives maximum revenue from SendTech Solutions.